SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-475602
Filing Date
2012-11-19
Accepted
2012-11-19 16:02:19
Documents
11
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d415954d10q.htm 10-Q 687442
2 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER d415954dex311.htm EX-31.1 7092
3 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER d415954dex312.htm EX-31.2 7241
4 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER d415954dex321.htm EX-32.1 3181
5 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER d415954dex322.htm EX-32.2 3252
  Complete submission text file 0001193125-12-475602.txt   4741070

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rgls-20120930.xml EX-101.INS 716968
7 XBRL TAXONOMY EXTENSION SCHEMA rgls-20120930.xsd EX-101.SCH 54102
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rgls-20120930_cal.xml EX-101.CAL 50838
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rgls-20120930_def.xml EX-101.DEF 249535
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgls-20120930_lab.xml EX-101.LAB 362499
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgls-20120930_pre.xml EX-101.PRE 287014
Mailing Address 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35670 | Film No.: 121214633
SIC: 2834 Pharmaceutical Preparations